Estrogen /progesterone receptor-gasdermin E axis links hormone signalling to pyroptotic cell death, anti-tumour immunity and response to chemotherapy in breast cancer cells

Hormone receptor signalling orchestrates different pathways in breast cancer (BC). Gasdermin E (GSDME), a key pyroptosis-inducing protein, has emerged as an important modulator of immunogenic cell death and anti-tumor immunity. We aim to investigate the regulatory and functional implications of the relationship between hormone receptors and GSDME expression in BC. The impact of hormone receptor inhibition/downregulation on GSDME level and activity was studied by immunofluorescence and lactate dehydrogenase release assay. The potential regulatory role of hormone receptors was tested by polymerase chain reaction, chromatin immunoprecipitation and dual luciferase reporter assay, while the influence of GSDME on the sensitivity of BC cell lines to doxorubicin was studied by sulforhodamine B. The impact of GSDME on cytotoxic immune cells was studied in patient samples. A mass spectroscopic analysis was done to define the pathways affected by GSDME downregulation. Our findings herein demonstrate for the first time that estrogen and progesterone receptors act as transcription repressors of GSDME in hormone receptor-positive BC cells. Pharmacological/biological inhibition of hormone receptors, led to a significant upregulation of GSDME, which facilitated its cleavage, membrane translocation of its N-terminal fragment and subsequent induction of pyroptosis. These events were accompanied by enhanced immune cell activation, including increased natural killer (NK) cell cytotoxicity and a favourable T cell infiltration. Collectively, our findings uncover a novel ER/PR-GSDME regulatory axis linking hormone receptor signalling to pyroptosis, chemosensitivity, and components of anti-tumor immunity in BC. This work highlights GSDME as a predictive biomarker for combination therapies involving hormone receptor inhibitors, chemotherapy, and immune checkpoint inhibitors (ICIs) in BC.

Authors

Institutions

Publication Details

Journal
Biomedicine & Pharmacotherapy
Published
2026-05-29
DOI
https://doi.org/10.1016/j.biopha.2026.119591
Primary Topic
Inflammasome and immune disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Estrogen /progesterone receptor-gasdermin E axis links hormone signalling to pyroptotic cell death, anti-tumour immunity and response to chemotherapy in breast cancer cells

Wael Mansour, Wafaa S. Ramadan, Lama Lozon, Varsha Menon et al.
Biomedicine & Pharmacotherapy
Inflammasome and immune disorders
article

Estrogen /progesterone receptor-gasdermin E axis links hormone signalling to pyroptotic cell death, anti-tumour immunity and response to chemotherapy in breast cancer cells

Wael Mansour, Wafaa S. Ramadan, Lama Lozon, Varsha Menon, Timo Gemoll, Sven Perner, Julika Ribbat-Idel, Thorben Sauer, Raafat El-Awady
article en

Abstract

Hormone receptor signalling orchestrates different pathways in breast cancer (BC). Gasdermin E (GSDME), a key pyroptosis-inducing protein, has emerged as an important modulator of immunogenic cell death and anti-tumor immunity. We aim to investigate the regulatory and functional implications of the relationship between hormone receptors and GSDME expression in BC. The impact of hormone receptor inhibition/downregulation on GSDME level and activity was studied by immunofluorescence and lactate dehydrogenase release assay. The potential regulatory role of hormone receptors was tested by polymerase chain reaction, chromatin immunoprecipitation and dual luciferase reporter assay, while the influence of GSDME on the sensitivity of BC cell lines to doxorubicin was studied by sulforhodamine B. The impact of GSDME on cytotoxic immune cells was studied in patient samples. A mass spectroscopic analysis was done to define the pathways affected by GSDME downregulation. Our findings herein demonstrate for the first time that estrogen and progesterone receptors act as transcription repressors of GSDME in hormone receptor-positive BC cells. Pharmacological/biological inhibition of hormone receptors, led to a significant upregulation of GSDME, which facilitated its cleavage, membrane translocation of its N-terminal fragment and subsequent induction of pyroptosis. These events were accompanied by enhanced immune cell activation, including increased natural killer (NK) cell cytotoxicity and a favourable T cell infiltration. Collectively, our findings uncover a novel ER/PR-GSDME regulatory axis linking hormone receptor signalling to pyroptosis, chemosensitivity, and components of anti-tumor immunity in BC. This work highlights GSDME as a predictive biomarker for combination therapies involving hormone receptor inhibitors, chemotherapy, and immune checkpoint inhibitors (ICIs) in BC.

Biomedicine & PharmacotherapyVol. 200
Universität Hamburg (DE), University of Sharjah (AE), University Medical Center Hamburg-Eppendorf (DE), University Hospital Schleswig-Holstein (DE), University Cancer Center Hamburg (DE), Technical University of Applied Sciences Lübeck (DE), University of Lübeck (DE)
Al Jalila Foundation
Good health and well-being
Openalex Percentile: Top 9%
Inflammasome and immune disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.